Home / Posts Tagged "Granules India"

Quote for International Women’s Day from Priyanka Chigurupati, Executive Director, Granules India Ltd. "As we commemorate International Women's Day, it's important to recognize the strides we have made towards gender equality yet acknowledge that we have miles to go. In the pharmaceutical industry, we are at

READ MORE

 Granules India Limited today announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Gabapentin Tablets USP, 600 mg and 800 mg. It is bioequivalent to the reference listed drug product (RLD), Neurontin Tablets, 600 mg and 800

READ MORE